← Leaderboards
Daniel James McGrail
University Of Tx Md Anderson Can Ctr
$1,543,247
Attributed
$1,764,622
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $811K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,764,622 · 4
By mechanism
R00$746,997 · 1
R21$442,750 · 1
R37$368,288 · 1
K99$206,587 · 1
Top collaborators
- Apollo Stacy1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Gregory Neal Fuller$1,533,596
- Guang Peng$3,599,803
- Scott Kopetz$13,199,822
- Guillermina Lozano$24,537,407
- Michael W Andreeff$17,991,896
Others in their field
Other Emerging Leaders on “Neoplastic Cell”
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Tina Garyantes · Linnaeus Therapeutics, Llc$6,999,960
- Zachary Scott Morris · University Of Wisconsin-Madison$6,108,830
- Samuel F Bakhoum · Weill Medical Coll Of Cornell Univ$6,006,178
- Gordon M Ringold · Quadriga Biosciences, Inc.$5,755,369
- Himisha Beltran · Dana-Farber Cancer Inst$5,409,904
Research focus
Neoplastic CellTumorOverexpressionProteinsResistanceResponseMalignant NeoplasmsInsightMutationSignal TransductionModalityClustered Regularly Interspaced Short Palindromic RepeatsLinkMediatingDna DamageImmuneGene DeletionCellsCrispr ScreenIn VivoGenesCohortImmune Checkpoint BlockadeMember
Grant awards (7)
Systematic identification of drivers controlling Fusobacterium and oral squamous cell carcinoma interactions$442,750
R21 · FY2025 · DE · contact PI
Molecular mediators of disparate outcomes experienced by patients of African ancestry with lung cancer$368,288
R37 · FY2025 · CA · contact PI
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes$248,999
R00 · FY2024 · CA · contact PI
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes$248,999
R00 · FY2023 · CA · contact PI
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes$248,999
R00 · FY2022 · CA · contact PI
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes$103,284
K99 · FY2020 · CA · contact PI
Determining the Immunological Consequences of DNA Replication Stress Response Defects in Renal Cells Carcinoma to Improve Immunotherapy Outcomes$103,303
K99 · FY2019 · CA · contact PI